A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors

Clinical trial NCT07028268 · RECRUITING

Trial details

NCT number: NCT07028268
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors

Start date: 2025-06-24
Primary completion: 2025-12-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.